Nadja A Vielot1, Yaoska Reyes2, Bryan Blette3, Fredman González2, Christian Toval-Ruiz2, Lester Gutiérrez2, Samuel Vilchez2, Marta Diez-Valcarce4,5, Jan Vinjé4, Sylvia Becker-Dreps1,6, Filemón Bucardo2. 1. From the Department of Family Medicine, University of North Carolina, Chapel Hill, NC. 2. Center of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua-León, León, Nicaragua. 3. Department of Biostatistics, University of North Carolina, Chapel Hill, NC. 4. Division of Viral Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA. 5. Emory University, Rollins School of Public Health, Atlanta, GA. 6. Department of Epidemiology, University of North Carolina, Chapel Hill, NC.
Abstract
BACKGROUND: Norovirus and sapovirus cause a large burden of acute gastroenteritis (AGE) in young children. We assessed protection conferred by norovirus and sapovirus AGE episodes against future episodes. METHODS: Between June 2017 and July 2018, we recruited 444 newborns in León, Nicaragua. Weekly household surveys identified AGE episodes over 36 months, and AGE stools were tested by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) for norovirus genogroup (G)I/GII and sapovirus. We used recurrent-event Cox models and negative control methods to estimate protection conferred by first episodes, controlling for observed and unobserved risk factors, respectively. RESULTS: Sapovirus episodes conferred a 69% reduced hazard of subsequent episodes using the negative control method. Norovirus GI (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.31, 1.3) and GII (HR = 0.20; 95% CI = 0.04, 0.44) episodes also appeared highly protective. Protection against norovirus GII was enhanced following two episodes. CONCLUSIONS: Evidence of natural immunity in early childhood provides optimism for the future success of pediatric norovirus and sapovirus vaccines.
BACKGROUND: Norovirus and sapovirus cause a large burden of acute gastroenteritis (AGE) in young children. We assessed protection conferred by norovirus and sapovirus AGE episodes against future episodes. METHODS: Between June 2017 and July 2018, we recruited 444 newborns in León, Nicaragua. Weekly household surveys identified AGE episodes over 36 months, and AGE stools were tested by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) for norovirus genogroup (G)I/GII and sapovirus. We used recurrent-event Cox models and negative control methods to estimate protection conferred by first episodes, controlling for observed and unobserved risk factors, respectively. RESULTS: Sapovirus episodes conferred a 69% reduced hazard of subsequent episodes using the negative control method. Norovirus GI (hazard ratio [HR] = 0.67; 95% confidence interval [CI] = 0.31, 1.3) and GII (HR = 0.20; 95% CI = 0.04, 0.44) episodes also appeared highly protective. Protection against norovirus GII was enhanced following two episodes. CONCLUSIONS: Evidence of natural immunity in early childhood provides optimism for the future success of pediatric norovirus and sapovirus vaccines.
Authors: R G Wyatt; R Dolin; N R Blacklow; H L DuPont; R F Buscho; T S Thornhill; A Z Kapikian; R M Chanock Journal: J Infect Dis Date: 1974-06 Impact factor: 5.226
Authors: F R Velázquez; D O Matson; J J Calva; L Guerrero; A L Morrow; S Carter-Campbell; R I Glass; M K Estes; L K Pickering; G M Ruiz-Palacios Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245
Authors: Preeti Chhabra; Saba Rouhani; Hannah Browne; Pablo Peñataro Yori; Mery Siguas Salas; Maribel Paredes Olortegui; Lawrence H Moulton; Margaret N Kosek; Jan Vinjé Journal: Clin Infect Dis Date: 2021-01-27 Impact factor: 20.999
Authors: Yaoska Reyes; Fredman González; Lester Gutiérrez; Patricia Blandón; Edwing Centeno; Omar Zepeda; Christian Toval-Ruíz; Lisa C Lindesmith; Ralph S Baric; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Lennart Svensson; Sylvia Becker-Dreps; Johan Nordgren; Filemón Bucardo Journal: J Infect Dis Date: 2022-01-05 Impact factor: 7.759
Authors: Sara M Pires; Christa L Fischer-Walker; Claudio F Lanata; Brecht Devleesschauwer; Aron J Hall; Martyn D Kirk; Ana S R Duarte; Robert E Black; Frederick J Angulo Journal: PLoS One Date: 2015-12-03 Impact factor: 3.240
Authors: James A Platts-Mills; Jie Liu; Elizabeth T Rogawski; Furqan Kabir; Paphavee Lertsethtakarn; Mery Siguas; Shaila S Khan; Ira Praharaj; Arinao Murei; Rosemary Nshama; Buliga Mujaga; Alexandre Havt; Irene A Maciel; Timothy L McMurry; Darwin J Operario; Mami Taniuchi; Jean Gratz; Suzanne E Stroup; James H Roberts; Adil Kalam; Fatima Aziz; Shahida Qureshi; M Ohedul Islam; Pimmada Sakpaisal; Sasikorn Silapong; Pablo P Yori; Revathi Rajendiran; Blossom Benny; Monica McGrath; Benjamin J J McCormick; Jessica C Seidman; Dennis Lang; Michael Gottlieb; Richard L Guerrant; Aldo A M Lima; Jose Paulo Leite; Amidou Samie; Pascal O Bessong; Nicola Page; Ladaporn Bodhidatta; Carl Mason; Sanjaya Shrestha; Ireen Kiwelu; Estomih R Mduma; Najeeha T Iqbal; Zulfiqar A Bhutta; Tahmeed Ahmed; Rashidul Haque; Gagandeep Kang; Margaret N Kosek; Eric R Houpt Journal: Lancet Glob Health Date: 2018-10-01 Impact factor: 26.763
Authors: Graham R Northrup; Lei Qian; Katia Bruxvoort; Florian M Marx; Lilith K Whittles; Joseph A Lewnard Journal: Epidemiology Date: 2021-03-01 Impact factor: 4.860